March 31, 2023 | Lactiga

Lactiga featured in the Globe and Mail

Jun 12, 2021

Lactiga featured in the Globe and Mail. Lactiga was featured in The Globe and Mail for its COVID-19 therapeutics program:...

Viraj Mane, Lactiga – Developing Novel Antibodies for Mucosal Infections in Rare Immunodeficiencies

Jun 11, 2021

Viraj Mane, Lactiga – Developing Novel Antibodies for Mucosal Infections in Rare Immunodeficiencies...

Lactiga featured in the Toronto Star

Jun 9, 2021

Lactiga featured in the Toronto Star Lactiga’s R&D on milk antibodies against COVID-19 was featured in the Toronto Star, one of Canada’s largest newspapers:...

Lactiga secures its American patent

Jun 9, 2021

Lactiga secures its American patent Lactiga received notification of issuance of its US patent, completing the first phase of its intellectual property...

Lactiga secures a Japanese patent

Jun 1, 2021

Lactiga secures a Japanese patent. Lactiga receives issuance of a Japanese patent, strengthening its global intellectual property...

In the News

November 9, 2021

Got milk COVID-19 antibodies?

https://www.thestar.com/business/mars/2021/06/09/got-milk-covid-19-antibodies.html?rf

In the News

November 9, 2021

Can antibodies from human breast milk help in the COVID-19 fight?

https://www.theglobeandmail.com/canada/article-can-antibodies-from-human-breast-milk-help-in-the-covid-19-fight/

Press Releases

November 1, 2021

Lactiga Announces NIH-Funded Partnership with Mount Sinai to Advance its Patented Biologic for COVID-19 Treatment

Original Post PRINCETON, N.J.--(BUSINESS WIRE)--Lactiga Inc., a biotechnology company advancing its patented anti-infective biologic, LCTG-001, announced today a collaboration agreement ...